Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used ... obstructive pulmonary disease (COPD) were surprisingly underrepresented among ...

Do inhaled corticosteroids elevate risk for pneumonia in patients with chronic obstructive pulmonary disease? Several clinical trials, observational studies, and meta-analyses suggest that they do ...

With COPD, you have lung damage that worsens over time. Trelegy Ellipta does not come as a generic drug. Trelegy Ellipta comes in a dry powder inhaler. Each active ingredient in Trelegy Ellipta ...

The obesity epidemic in the US is growing, with rising use of antiobesity medications, especially for diabetes management. Evaluating medication effectiveness, cost, and accessibility is crucial ...

The research showed that that between October – November 2022, an average of 258,202 people were dispensed medication licensed for asthma and/or COPD in ... take your steroid inhaler as ...

Research shows more than 45,000 patients received multiple prescriptions for the tablets in a 12-month period Nearly one-in-five people who received medication for asthma or COPD were prescribed ...

COPD requires regular monitoring through tests like spirometry to assess the condition’s severity and aid in an individualized treatment plan. COPD is a progressive lung condition that makes ...

Symptoms may worsen during allergy season, and medications may be necessary. In addition to first-line treatments, those with allergic asthma may also benefit from antihistamines. While more commonly ...

and dry powder inhalers used by more patients aged 40 to 60 years. Patients with asthma and chronic obstructive pulmonary disease (COPD) routinely switch from pressurized metered-dose inhalers (pMDIs) ...

Ohtuvayre is the first novel inhaled mechanism for the maintenance treatment of COPD in more than 20 years. The analyses will summarize the efficacy and safety of Ohtuvayre in subgroups of COPD ...